Elite Pharmaceuticals Launches Generic Requip XL
Elite Pharmaceuticals announced the U.S. commercial launch of its generic Requip XL tablets, a non-ergoline dopamine agonist used to treat Parkinson's disease. The product offers a competitive entry into a market with $10 million in annual branded sales.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day